Tianen Zhou

Tianen Zhou


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
ZYZhengfei Yang
Zhengfei Yang
HLHeng Li
Heng Li
TYTao Yu
Tao Yu
CCChangwei Chen
Changwei Chen
JXJiefeng Xu
Jiefeng Xu
ZHZitong Huang
Zitong Huang

1 March 2020 in Toxicology in Vitro
Verified
Journal Article
Closed access
YLYanran Liang
Yanran Liang
DZDezhi Zheng
Dezhi Zheng
SPSudan Peng
Sudan Peng
DLDanyu Lin
Danyu Lin
XJXiuna Jing
Xiuna Jing
ETEnxiang Tao
Enxiang Tao

30 October 2025 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
XZXuan Zeng
Xuan Zeng
JZJingxin Zhao
Jingxin Zhao
YNYichu Nie
Yichu Nie
JMJierong Mo
Jierong Mo
TZTianen Zhou
Tianen Zhou
JJJun Jiang
Jun Jiang

1 May 2025 in Digital Health
Verified
Journal Article
Open access
ZLZhiyong Lin
Zhiyong Lin
JDJingyi Deng
Jingyi Deng
SCShiming Chen
Shiming Chen
JHJiawen He
Jiawen He
ZLZhiquan Li
Zhiquan Li
TZTianen Zhou
Tianen Zhou
Objective: Sepsis remains a critical global healthcare challenge with high mortality rates, where traditional diagnostics lack sensitivity and standardized treatments show limited efficacy due to patient variability. While artificial intelligence (AI) has advanced sepsis diagnosis and management, systematic bibliometric analyses are scarce, particularly regarding recent research trends from 2022 to 2025. This study aims to reveal research development patterns and frontier dynamics of AI applications in sepsis diagnosis and management, providing strategic guidance and decision support for researchers, clinicians, and policymakers in this rapidly evolving field. Methods: Web of Science data related to AI in sepsis published from 2005 to 2025 were retrieved. Multidimensional bibliometric and visualization analyses were conducted using VOSviewer, CiteSpace, and Bibliometrix packages. Results: AI applications in sepsis research demonstrated exponential growth since 2016, peaking at 352 publications and 1363 citations in 2024. The United States dominates both publication volume (487 papers) and citation impact (12,984 citations), while China ranks second in output (457 papers) but shows significantly lower impact (3929 citations). Research clustered into six major directions encompassing intelligent prediction, molecular mechanisms, and deep learning early warning systems. Post-2022 analysis revealed emerging keywords including “ARDS (Acute Respiratory Distress Syndrome),” “MIMIC-IV,” and “immune infiltration,” signaling shifts toward multi-omics integration and precision medicine. The most highly cited studies focused on sepsis phenotypic subtyping (776 citations) and AI treatment strategies (619 citations). Conclusion: AI applications in sepsis research are transitioning from algorithm validation toward clinical application, developing in the direction of explainable AI and precision sepsis care. The research trajectory evolves from “proof of concept” toward “ensuring clinical utility.” These findings provide strategic guidance for healthcare systems, highlighting the importance of interpretable models, multi-center validation, and infrastructure development for next-generation precision sepsis management.

12 May 2026 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
XZXuan Zeng
Xuan Zeng
YZYuying Zheng
Yuying Zheng
PCPan Chen
Pan Chen
YNYichu Nie
Yichu Nie
JMJierong Mo
Jierong Mo
JJJun Jiang
Jun Jiang

11 November 2025 in Internal and Emergency Medicine
Verified
Journal Article
Closed access
PDF file
ZLZhiyong Lin
Zhiyong Lin
RZRan Zhan
Ran Zhan
JMJierong Mo
Jierong Mo
JJJun Jiang
Jun Jiang
TZTianen Zhou
Tianen Zhou